Reuters logo
BRIEF-Idogen: important patent application receives Notice of Allowance from USPTO
March 13, 2017 / 2:23 PM / 7 months ago

BRIEF-Idogen: important patent application receives Notice of Allowance from USPTO

March 13 (Reuters) - Idogen AB:

* Says the United States Patent & Trademark Office (USPTO) has issued a “Notice of Allowance”, which means that it intends to grant Idogen’s patent application

* Patent term will then extend to December 2031, potentially longer if adjustment is made for any delays in the processing at the patent office

* Patent covers Idogen’s technology for induction of IDO for treatment of autoimmune diseases and transplant rejection

Source text: bit.ly/2miYWHs

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below